Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems' stock price has decreased by 30.5% since January 1, 2026. Despite better-than-expected Q1 2026 earnings, the stock declined following its Q4 2025 earnings report and 2026 guidance, leading to analyst downgrades and reduced price targets. The company's acquisition of View Point Medical and the divestiture of DualCap also impacted the stock.

Information specifically detailing the seasonality of demand for Merit Medical Systems' products and services is not readily available. Demand is likely driven by ongoing healthcare needs and medical procedures rather than significant seasonal fluctuations.

Merit Medical Systems, Inc. specializes in disposable medical devices for interventional, diagnostic, and therapeutic procedures, focusing on cardiology, radiology, oncology, critical care, and endoscopy. The company's product portfolio includes vascular access, drainage, embolotherapy, interventional oncology devices, radiofrequency ablation systems, and hemostasis solutions. Merit Medical's business is divided into Cardiovascular and Endoscopy segments, catering to physicians and hospitals in critical care settings.

Merit Medical Systems is headquartered in South Jordan, Utah, and has a global presence with manufacturing and distribution facilities across North America, Europe, and Asia. Its products are sold in over 90 countries, supported by regional sales offices in Europe, Latin America, and the Asia-Pacific region. The company exports its products to diverse markets, including Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa.

Merit Medical Systems generally holds a positive brand reputation among analysts, with a consensus rating of "Moderate Buy". The company's commitment to innovation, quality, and customer education contributes to its standing in the healthcare industry. A past FDA warning letter concerning quality control at a manufacturing facility has been highlighted as a key risk.

Merit Medical Systems, Inc. has a high percentage of institutional ownership, approximately 99.66%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and State Street Corp. Insiders hold a smaller percentage of the stock, around 0.70% to 2.62%, with Fred P. Lampropoulos being the largest individual shareholder.